ProteoTech's Grant - III Round

ProteoTech raised a round of funding on August 16, 2004. Investors include Small Business Innovation Research Awards.

ProteoTech is a private drug development company focused on targeting amyloid diseases. ProteoTech is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of…

Articles about ProteoTech's Grant - III Round: